goldman3_Karen DuceyGetty Images_antibodycoronaviruslab Karen Ducey/Getty Images

The Case for COVID-19 Antibody Therapies

 and 

Given the limitations of existing drugs and the uncertainty regarding vaccines, the world must also focus on developing new weapons to target the SARS-CoV-2 virus that causes COVID-19. Besides anti-viral chemical drugs, genetically engineered antibodies might be ideal for this purpose.

BRUSSELS/GENEVA – As many countries progressively relax their COVID-19 containment measures, preventing a renewed spread of the coronavirus from emerging infection clusters will be key to controlling the pandemic. And this will require the world to develop innovative new treatments.

https://prosyn.org/TUtHZ2D